The original hepatitis C virus antibody test against the C100 antigen has been replaced by a
second-generation recombinant immunoblot assay that detects antibodies against four viral …

In viral infections persistence of the virus is not always associated with virus-induced
disease. To find out if active hepatitis C virus (HCV) infection can persist without liver …

Multiplex analysis of antiviral antibody (Ab) responses provides a potentially powerful
strategy for viral diagnosis, prognostication, and development of vaccines and prophylactic …

Recently, it was demonstrated in chronic hepatitis C that the release of IgG and IgM anti‐
HCV antibodies by mononuclear cells (PBMCs) correlated with inflammatory activity, HCV …

It has been reported that the avidity of specific IgG antibody is lower in primary viral infection
than in chronic viral infection. However, few studies have been reported on the IgG avidity in …

An assay to measure avidity index (AI) was developed to diagnose incident hepatitis C virus
(HCV) infections. The assay demonstrated an AI value statistically significantly lower in …

Since the discovery of the hepatitis C virus (HCV), it has become evident that this infectious
agent is a primary cause of posttransfusion and sporadic non-A, non-B hepatitis …

Antiviral treatment of chronic hepatitis C with interferon is reviewed. Alpha-interferon, both
recombinant alpha-2a,-2b and human lymphoblastoid interferon given at a dose of≥ 3MU …

The significance of immunoglobulin (Ig) M antibody to hepatitis C virus core protein (IgM anti-
HCVcore) was studied in 41 patients with chronic hepatitis C virus (HCV) infection …

The aim was to assess the specificity and functional significance of liver‐infiltrating and
peripheral blood T cells in chronic hepatitis C. Peripheral blood mononuclear cells hepatitis …